BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1860421)

  • 1. [Tryptophan-induced fasciitis-scleroderma-eosinophilia syndrome].
    Schnabel A; Reinhold-Keller E; Wolff HH; Gross WL
    Dtsch Med Wochenschr; 1991 Aug; 116(31-32):1180-5. PubMed ID: 1860421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [L-tryptophan-induced eosinophilia-myalgia syndrome with features of diffuse fasciitis with eosinophilia].
    Senff H; Köllner A; Engelmann L; Woort-Menker M; Mensing H; Kunze J
    Hautarzt; 1990 Oct; 41(10):578-82. PubMed ID: 2258302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eosinophilia-myalgia syndrome and L-tryptophan intake].
    von Gizycki-Nienhaus B; Meurer M; Krieg T; Braun-Falco O
    Hautarzt; 1991 Mar; 42(3):179-82. PubMed ID: 1829070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.
    Silver RM; Heyes MP; Maize JC; Quearry B; Vionnet-Fuasset M; Sternberg EM
    N Engl J Med; 1990 Mar; 322(13):874-81. PubMed ID: 1690352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleroderma-like fasciitis without eosinophilia after L-tryptophan ingestion.
    Schlessel K; Greenwald R; Hirschfield L
    J Rheumatol; 1991 May; 18(5):779-82. PubMed ID: 1865433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Eosinophilia-myalgia syndrome after L-tryptophan intake].
    Zillikens D; Bammel A; Lurz C; Elsner P; Burg G
    Hautarzt; 1991 Mar; 42(3):154-7. PubMed ID: 2055764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination.
    Blauvelt A; Falanga V
    Arch Dermatol; 1991 Aug; 127(8):1159-66. PubMed ID: 1863073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eosinophilia-myalgia syndrome].
    Reinauer S; Plewig G
    Hautarzt; 1991 Mar; 42(3):137-9. PubMed ID: 2055761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use.
    Varga J; Griffin R; Newman JH; Jimenez SA
    J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration].
    Schnabel A; Reusch M; Christophers E; Gross WL
    Internist (Berl); 1994 Jan; 35(1):63-6. PubMed ID: 8144322
    [No Abstract]   [Full Text] [Related]  

  • 11. Tryptophan-induced eosinophilia-myalgia syndrome.
    Criswell LA; Sack KE
    West J Med; 1990 Sep; 153(3):269-74. PubMed ID: 2219890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic fasciitis associated with L-tryptophan ingestion.
    Grigoris I; de Launey W; Jevtic AP
    Med J Aust; 1992 Sep; 157(5):329-30. PubMed ID: 1435477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis.
    Freundlich B; Werth VP; Rook AH; O'Connor CR; Schumacher HR; Leyden JJ; Stolley PD
    Ann Intern Med; 1990 May; 112(10):758-62. PubMed ID: 2331120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
    Hertzman PA; Blevins WL; Mayer J; Greenfield B; Ting M; Gleich GJ
    N Engl J Med; 1990 Mar; 322(13):869-73. PubMed ID: 2314421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of MRI in the evaluation of fasciitis with eosinophilia induced by L-tryptophan. Apropos of 3 new cases].
    Montane de la Roque P; Laroche M; Arlet P; Massip P; Rousseau H; Blain F; Juchet H; Duffaut M; le Tallec Y
    Rev Rhum Mal Osteoartic; 1991 Dec; 58(12):887-9. PubMed ID: 1780671
    [No Abstract]   [Full Text] [Related]  

  • 16. [Eosinophilia-myalgia syndrome with fasciitis and interstitial myositis after L-tryptophan administration].
    Bartz-Bazzanella P; Genth E; Pollmann HJ; Schröder JM; Völker A
    Z Rheumatol; 1992; 51(1):3-13. PubMed ID: 1574934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation].
    Frick P; Frey R
    Schweiz Med Wochenschr; 1990 Nov; 120(44):1633-5. PubMed ID: 2251478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eosinophilic fasciitis; the importance of early detection for optimal outcomes].
    Hokken JW; van den Wall Bake AW; de Nijs RN; Westgeest AA; Kroot EJ; van Lijnschoten G
    Ned Tijdschr Geneeskd; 2008 Mar; 152(12):657-62. PubMed ID: 18438058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
    Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
    Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eosinophilic fasciitis. A report of a clinical case and the current concepts for its diagnosis and treatment].
    Achurra AF; Mendieta MC; Llerena JM; Benitez R
    Rev Med Panama; 1997 Jan; 22(1):39-44. PubMed ID: 9805093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.